Retatrutide and trizepatide constitute a recent class of medications that bind to both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. These multifunctional https://inescbdb103040.wikinewspaper.com/user